Health Condition 1: T702- Other and unspecified effects of high altitude
Conditions
Interventions
Intervention1: Homoeopathic medicine Coca in 30 CH potency: Homoeopathic drug Coca 30CH will be used in the study. The drug identified for the trial shall be procured from a GMP-compliant pharmaceutic
Sponsors
Central Council for Research in Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: i. All the fresh low landers/Travelers/tourists who had rapid ascent to high altitude ( >2400 m) in last 1-2 days. ii. Mild to moderate cases of AMS having minimum score 3 according to Lake Louise AMS score. iii. Controlled cases of Diabetes Mellitus and Hypertension. iv. Written informed consent from the patient.
Exclusion criteria
Exclusion criteria: i. Severe cases of AMS like High-altitude pulmonary oedema (HAPE) or& High-altitude cerebral oedema (HACE) or having score of more than 10 on Lake Louise AMS score. ii. On any strong other medications like steroids or prophylactic medicine for AMS within one week before enrolment. iii. Patients who are immune compromised. iv. Pregnant and lactating women. v. Known cases of uncontrolled diabetes, hypertension, cardiac, pulmonary, or other chronic disease that would render them at increased risk of altitude illness. vi. Any pre-existing mental disorder or respiratory diseases like COPD, Asthma etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To see if there is any development of AMS symptoms between the three arms of intervention. Changes in severity of Acute Mountain sickness using Lake Louise AMS score between the three arms. Timepoint: Baseline, daily follow up till 07 days. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare changes in pulse saturation & heart rateTimepoint: Baseline & at the end of the intervention | — |
Countries
India
Contacts
Public ContactDr Deepti Singh
Central Council for Research in Homoeopathy
Outcome results
None listed